Chandan Healthcare Ltd

Chandan Healthca Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Chandan Healthcare Ltd

₹ 189 -2.78%
29 Apr 3:32 p.m.
Company website NSE - SME: CHANDAN
About

Incorporated in September 2003, Chandan Healthcare Limited runs diagnostic centers in North India with pathology and radiology testing services.[1]

Key Points

Business Profile[1]
Chandan Healthcare Limited operates a diagnostic network in North India that offers pathology and radiology testing services. The company has a presence in Uttar Pradesh, Uttarakhand, and Jaipur (Rajasthan), with a strong network of labs, satellite centers, and collection points

Website NSE - SM
  • Market Cap ₹ 461 Cr.
  • Current Price ₹ 189
  • High / Low ₹ 215 / 140
  • Stock P/E 28.8
  • Book Value ₹
  • Dividend Yield 0.00 %
  • ROCE 40.8 %
  • ROE 47.6 %
  • Face Value ₹ 10.0
Edit ratios

Pros

Cons

  • Promoter holding has decreased over last quarter: -20.7%
  • Debtor days have increased from 72.9 to 88.9 days.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Healthcare Industry: Healthcare

Edit Columns
Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Operating Profit
OPM %
Interest
Depreciation
Profit before tax
Tax %
EPS in Rs
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
67 56 72 76 100
60 51 69 67 75
Operating Profit 6 5 3 9 25
OPM % 9% 9% 4% 12% 25%
0 0 0 0 1
Interest 2 2 2 2 2
Depreciation 2 2 2 2 3
Profit before tax 2 1 -1 5 21
Tax % 39% 45% 93% 23% 24%
1 1 -1 4 16
EPS in Rs 0.71 0.41 -0.68 2.02 8.01
Dividend Payout % 0% 0% 0% 0% 0%
Compounded Sales Growth
10 Years: %
5 Years: %
3 Years: 21%
TTM: 32%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: 169%
TTM: 297%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: %
1 Year: %
Return on Equity
10 Years: %
5 Years: %
3 Years: 23%
Last Year: 48%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Equity Capital 20 20 20 20 20
Reserves 4 5 3 7 21
15 14 15 17 29
20 18 22 26 26
Total Liabilities 59 56 59 70 95
20 20 25 28 44
CWIP 0 0 0 0 0
Investments 20 11 14 15 13
19 25 21 27 39
Total Assets 59 56 59 70 95

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
-7 7 8 3
7 -10 -8 -11
-0 -2 -2 9
Net Cash Flow 0 -4 -2 0

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Debtor Days 54 76 53 77 89
Inventory Days 88 78 37 9 179
Days Payable 126 224 233 399 149
Cash Conversion Cycle 15 -69 -143 -314 119
Working Capital Days -33 34 -16 -25 43
ROCE % 9% 2% 18% 41%

Shareholding Pattern

Numbers in percentages

9 Recently
Mar 2025
49.43%
3.86%
6.32%
40.38%
No. of Shareholders 897

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

No data available.

Credit ratings